Tissue distribution and subcellular localization of a variant form of the human ST2 gene product, ST2V.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  2001-08-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1006/BBRC.2001.5306PMID 11478810
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The cloning and nucleotide sequence of human ST2L cDNA.

  2000cited by this paper
• T1/St2-Deficient Mice Demonstrate the Importance of T1/St2 in Developing Primary T Helper Cell Type 2 Responses

  2000cited by this paper
• Construction of ELISA System to Quantify Human ST2 Protein in Sera of Patients

  2000cited by this paper
• T1/ST2 expression is enhanced on CD4+ T cells from schistosome egg-induced granulomas: analysis of Th cell cytokine coexpression ex vivo.

  1999cited by this paper
• The Absence of Interleukin 1 Receptor–Related T1/St2 Does Not Affect T Helper Cell Type 2 Development and Its Effector Function

  1999cited by this paper
• Presence and expression of a novel variant form of ST2 gene product in human leukemic cell line UT-7/GM.

  1999cited by this paper
• Bacterial Lipopolysaccharide Activates Nuclear Factor-κB through Interleukin-1 Signaling Mediators in Cultured Human Dermal Endothelial Cells and Mononuclear Phagocytes*

  1999cited by this paper
• Crucial Role of the Interleukin 1 Receptor Family Member T1/St2 in T Helper Cell Type 2–Mediated Lung Mucosal Immune Responses

  1999cited by this paper
• Different promoter usage and multiple transcription initiation sites of the interleukin-1 receptor-related human ST2 gene in UT-7 and TM12 cells.

  1999cited by this paper
• Expression of Th2 cytokines and the stable Th2 marker ST2L in the absence of IL‐4 during Leishmania major infection

  1999cited by this paper
• Selective Expression of a Stable Cell Surface Molecule on Type 2 but Not Type 1 Helper T Cells

  1998cited by this paper
• Interleukin-18 activates the IRAK-TRAF6 pathway in mouse EL-4 cells.

  1998cited by this paper
• Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function.

  1998cited by this paper
• T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function.

  1998cited by this paper
• The expression of ST2 gene in helper T cells and the binding of ST2 protein to myeloma-derived RPMI8226 cells.

  1997cited by this paper
• MyD88: an adapter that recruits IRAK to the IL-1 receptor complex.

  1997cited by this paper
• Assignment of the human ST2 gene to chromosome 2 at q11.2

  1996cited by this paper
• T1/ST2 Signaling Establishes It as a Member of an Expanding Interleukin-1 Receptor Family (*)

  1996cited by this paper
• TRAF6 is a signal transducer for interleukin-1

  1996cited by this paper
• Cloning of a Putative Ligand for the T1/ST2 Receptor (*)

  1996cited by this paper
• IRAK: A Kinase Associated with the Interleukin-1 Receptor

  1996cited by this paper
• TRAF6 is a signal transducer for interleukin-1.

  1996cited by this paper
• ST2/T1 Protein Functionally Binds to Two Secreted Proteins from Balb/c 3T3 and Human Umbilical Vein Endothelial Cells but Does Not Bind Interleukin 1 (*)

  1995cited by this paper
• Studies on Natural ST2 Gene Products in the Human Leukemic Cell Line UT-7 Using Monoclonal Antihuman ST2 Antibodies

  1995cited by this paper
• Alternative promoter usage of the Fos‐responsive gene Fit‐1 generates mRNA isoforms coding for either secreted or membrane‐bound proteins related to the IL‐1 receptor.

  1994cited by this paper
• Presence of a novel primary response gene ST2L, encoding a product highly similar to the interleukin 1 receptor type 1

  1993cited by this paper
• Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4.

  1993cited by this paper
• Nucleotide sequence of a complementary DNA for human ST2.

  1992cited by this paper
• Molecular cloning of the murine ST2 gene. Characterization and chromosomal mapping.

  1991cited by this paper
• pEF-BOS, a powerful mammalian expression vector.

  1990cited by this paper
• A putative protein of a growth specific cDNA from BALB/C‐3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor

  1989cited by this paper
• Induction of a mitogen-responsive gene after expression of the Ha-ras oncogene in NIH 3T3 fibroblasts

  1989cited by this paper

• The Effect and Mechanism of IL-33 on Decidual Immune Cell Function at Maternal-Fetal Interface

  2025cites this paper
• Spatial and Functional Characterization of IL1RL1+ Mast Cells Reveals Immune Regulatory Roles in Renal Cancer.

  2025cites this paper
• Downregulation of sST2, a decoy receptor for interleukin‐33, enhances subcutaneous tumor growth in murine pancreatic cancer cells

  2025cites this paper
• Evaluation of soluble suppression of tumorigenicity 2 (sST2) as serum marker for liver fibrosis

  2024cites this paper
• The ST2/IL-33 Pathway in Adult and Paediatric Heart Disease and Transplantation

  2023cites this paper
• Alternative splicing events and function in the tumor microenvironment: New opportunities and challenges.

  2023cites this paper
• Interleukin-33 as a Potential Therapeutic Target in Gastric Cancer Patients: Current Insights

  2023cites this paper
• Clinicopathological and Prognostic Relevance of Tumoral Suppression of Tumorigenicity 2 Expression in Patients With Surgically Resected Pancreatic Carcinoma.

  2023cites this paper
• Sex and age differences in sST2 in cardiovascular disease

  2023cites this paper
• The Role of Alarmins in Osteoarthritis Pathogenesis: HMGB1, S100B and IL-33

  2023cites this paper
• Soluble suppression of tumorigenicity-2 in pregnancy with a small-for-gestational-age fetus and with preeclampsia

  2022cites this paper
• Paradoxical role of interleukin-33/suppressor of tumorigenicity 2 in colorectal carcinogenesis: Progress and therapeutic potential

  2022cites this paper
• IL-33 promotes gastric tumour growth in concert with activation and recruitment of inflammatory myeloid cells

  2022cites this paper
• IL-33 biology in cancer: An update and future perspectives.

  2022cites this paper
• Epithelial cell alarmin cytokines: Frontline mediators of the asthma inflammatory response

  2022cites this paper
• Growth stimulation expressed gene 2 (ST2): Clinical research and application in the cardiovascular related diseases

  2022cites this paper
• Signaling and functions of interleukin-33 in immune regulation and diseases

  2022cites this paper
• Role of the IL-33/ST2 receptor axis in ovarian cancer progression.

  2021cites this paper
• The central role of IL-33/IL-1RL1 pathway in asthma: From pathogenesis to intervention.

  2021cites this paper
• Emerging Noninvasive Biomarkers, and Medical Management Strategies for Alcoholic Hepatitis: Present Understanding and Scope

  2020cites this paper
• Pathophysiological roles of chronic low‐grade inflammation mediators in polycystic ovary syndrome

  2020cites this paper
• IL-33/sST2 axis in The Cardiovascular System: A Brief Review

  2020cites this paper
• Cancer cell-derived interleukin-33 decoy receptor sST2 enhances orthotopic tumor growth in a murine pancreatic cancer model

  2020cites this paper
• Biomarkers of IL-33 and sST2 and Lack of Association with Carvedilol Therapy in Heart Failure

  2020cites this paper
• IL-33/ST2 Axis as a Well-Known Endogenous Defense Against Tuberculosis

  2020cites this paper
• The Functional Roles of IL-33/ST2 Axis in Ocular Diseases

  2020cites this paper
• Hepatitis B virus X protein (HBx) promotes ST2 expression by GATA2 in liver cells.

  2020cites this paper
• The Biological Context of C-Reactive Protein as a Prognostic Marker in Renal Cell Carcinoma: Studies on the Acute Phase Cytokine Profile

  2020cites this paper
• CPAA_A_256290 53..58

  2020cites this paper
• ST2/IL-33 signaling in cardiac fibrosis.

  2019cites this paper
• The ST2/Interleukin-33 Axis in Hematologic Malignancies: The IL-33 Paradox

  2019cites this paper
• Genetic variants in IL-33/ST2 pathway with the susceptibility to hepatocellular carcinoma in a Chinese population.

  2019cites this paper
• Interleukin-33 and ST2 Signaling in Tumor Microenvironment

  2019cites this paper
• Role of the IL-33/ST2/p38 signaling pathway in the immune response of corneal epithelial cells to Aspergillus fumigatus infection.

  2019cites this paper
• ST2 and the ST2/IL-33 signalling pathway-biochemistry and pathophysiology in animal models and humans.

  2019cites this paper
• The predictive role for ST2 in patients with acute coronary syndromes and heart failure.

  2019cites this paper
• Systematic evaluation of isoform function in literature reports of alternative splicing

  2018cites this paper
• Role of the IL-33/ST2L axis in colorectal cancer progression.

  2018cites this paper
• Critical Roles of IL-33/ST2 Pathway in Neurological Disorders

  2018cites this paper
• Predicting asthma phenotypes: characterization of IL1RL1 in asthma

  2018cites this paper
• Chapter 2 Biomarkers for Risk Prediction in Acute Decompensated Heart Failure

  2018influential citation
• ST2/MYD88 signaling is a therapeutic target alleviating murine acute graft-versus-host disease sparing T regulatory cell function

  2018cites this paper
• The family of the interleukin‐1 receptors

  2018cites this paper
• Genetic regulation of IL1RL1 methylation and IL1RL1-a protein levels in asthma

  2018cites this paper
• INTERLEUKIN 33 AND FIBROSIS : PATHOGENESIS UPDATED

  2018influential citation
• Plasma levels of soluble ST2, but not IL‐33, correlate with the severity of alcoholic liver disease

  2018cites this paper
• The Role of IL-33/ST2 Pathway in Tumorigenesis

  2018cites this paper
• What is the role of interleukin 33 and ST2 receptor in myasthenia gravis?

  2018cites this paper
• The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases

  2017cites this paper
• IL33 and IL1RL1 variants are associated with asthma and atopy in a Brazilian population

  2017cites this paper
• ST2 from rainbow trout quenches TLR signalling, localises at the nuclear membrane and allows the nuclear translocation of MYD88

  2017cites this paper
• IL‐33 and the intestine: The good, the bad, and the inflammatory

  2017cites this paper
• IL-33-ST2 Axis in Liver Disease: Progression and Challenge

  2017cites this paper
• T1/ST2 deficient mice display protection against Leishmania infantum experimental infection.

  2017cites this paper
• Effects of obesity on IL-33/ST2 system in heart, adipose tissue and liver: study in the experimental model of Zucker rats.

  2017cites this paper
• Interleukin-33 enhances programmed oncosis of ST2L-positive low-metastatic cells in the tumour microenvironment of lung cancer

  2016cites this paper
• Antiallergic Effects of Anti-Interleukin-33 are Associated with Suppression of Immunoglobulin Light Chain and Inducible Nitric Oxide Synthase

  2016cites this paper
• Soluble IL-33 receptor sST2 inhibits colorectal cancer malignant growth by modifying the tumour microenvironment

  2016cites this paper
• IL-33 Signaling in Lung Injury.

  2016cites this paper
• The IL-1 cytokine family and its role in inflammation and fibrosis in the lung

  2016cites this paper
• Anti-interleukin-33 Reduces Ovalbumin-Induced Nephrotoxicity and Expression of Kidney Injury Molecule-1

  2016cites this paper
• Interleukin-33, friend and foe in type-2 immune responses.

  2016cites this paper
• Interleukin-33/ST2 system attenuates aldosterone-induced adipogenesis and inflammation.

  2015cites this paper
• The potential role of IL‐33/ST2 signaling in fibrotic diseases

  2015cites this paper
• The IL-33/ST2 axis: Role in health and disease.

  2015cites this paper
• Increased Serum Levels of the IL‐33 Neutralizing sST2 in Limited Cutaneous Systemic Sclerosis

  2015cites this paper
• Soluble ST2 in Ventricular Dysfunction.

  2015cites this paper
• Interleukin-33 and Mast Cells Bridge Innate and Adaptive Immunity: From the Allergologist’s Perspective

  2015cites this paper
• Cytokine & Growth Factor Reviews

  2015cites this paper
• Przydatność rokownicza nowych markerów w przewlekłej skurczowej niewydolności serca = The prognostic usefulness of new markers in chronic systolic heart failure

  2015cites this paper
• The Association of Serum IL-33 and sST2 with Breast Cancer

  2015cites this paper
• The Role of the Serum IL-33/sST2 Axis and Inflammatory Cytokines in Chronic Obstructive Pulmonary Disease

  2014cites this paper
• Novel Biomarkers in Heart Failure Beyond Natriuretic Peptides - The Case for Soluble ST2.

  2014cites this paper
• Biomarkers for Risk Prediction in Acute Decompensated Heart Failure

  2014cites this paper
• [Biological role of Interleukin 33 and its importance in pathophysiology of cardiovascular system].

  2014cites this paper
• Increased serum soluble ST2 in asthmatic children and recurrent early wheezers

  2014cites this paper
• Various Forms of Tissue Damage and Danger Signals Following Hematopoietic Stem-Cell Transplantation

  2014cites this paper
• Murine Mast Cells Secrete and Respond to Interleukin-33

  2014cites this paper
• Functional analysis of polymorphisms in asthma genes : TSLP and IL1RL1

  2014cites this paper
• The variations in the IL1RL1 gene and susceptibility to preeclampsia

  2014cites this paper
• Serum soluble ST2 is associated with ER-positive breast cancer

  2014cites this paper
• Regulation of interleukin 33/ST2 signaling of human corneal epithelium in allergic diseases.

  2013cites this paper
• The GOLD Domain-containing Protein TMED1 Is Involved in Interleukin-33 Signaling*

  2013cites this paper
• Analyses post-génomiques : étude de l'implication d'IL-33 et de BIN1 dans la physiopathologie de la maladie d'Alzheimer

  2013cites this paper
• IL-33 in rheumatoid arthritis: potential role in pathogenesis and therapy.

  2013cites this paper
• Signaling TMED 1 Is Involved in Interleukin-33 The GOLD Domain-containing Protein Immunology :

  2013cites this paper
• Increased Serum Soluble ST2 In Asthmatic Children and Recurrent Early Wheezers

  2013cites this paper
• The interleukin-1 receptor family.

  2013cites this paper
• A Role for Soluble ST2 in Vascular Remodeling Associated with Obesity in Rats

  2013cites this paper
• The Role of Interleukin-33 in Rhinitis

  2013cites this paper
• Place de l'Interleukine-33 dans la réponse immune du foie au cours de la leishmaniose viscérale

  2013cites this paper
• Increased Nasal Interleukin-33 in the Infants with Acute Respiratory Syncytial Virus Bronchiolitis

  2012cites this paper
• Mast Cells Respond to Cell Injury through the Recognition of IL-33

  2012cites this paper
• IL-33

  2012cites this paper
• Heart failure biomarkers: focus on interleukin-1 receptor-like 1-based blood tests.

  2012cites this paper
• Anti‐IL‐33 antibody has a therapeutic effect in a murine model of allergic rhinitis

  2012cites this paper
• Adenovirus‐mediated delivery of soluble ST2 attenuates ovalbumin‐induced allergic asthma in mice

  2012cites this paper
• Beneficial Effect of Anti-Interleukin-33 on the Murine Model of Allergic Inflammation of the Lower Airway

  2012cites this paper
• [Interleukin-33/ST2: a new signaling pathway in immunity and immunopathology].

  2012cites this paper
• ST2 deletion enhances innate and acquired immunity to murine mammary carcinoma

  2011cites this paper